Riskpilot← Back to searchSign inGet full accessCELLINK Bioprinting AB
ABActiveOrg 5593146169Långfilsgatan 7Manufacture of computers and peripheral equipment · NACE 2620Est. 202120-49 employees
Revenue 2024
SEK 89,8M
-23% vs 2023
EBITDA margin
-116.1%
-318% vs 2023
Equity ratio
17.9%
Financial strength
Net profit 2024
SEK 42,9M
+166% vs 2023
| Revenue | SEK 89,8M | -23% |
| EBITDA | SEK -104,3M | -318% |
| Net profit | SEK 42,9M | +166% |
| Total assets | SEK 321,3M | -15% |
| Equity | SEK 57,6M | +293% |
| Employees | — | — |
Legal name
CELLINK Bioprinting AB
Org number
5593146169
Legal form
Aktiebolag
NACE code
2620 · Manufacture of computers and peripheral equipment
Founded
28 april 2021
Share capital
SEK 25 000
Employees
20-49
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska vara verksamt inom 3D-bioprinting. Bolaget ska utveckla, producera och sälja biologiskt bläck, 3D-Bioskrivare ämnade för utskrift av 3D-cellkulturer samt tillhörande utrustning och därmed förenlig verksamhet. Bolaget ska även förvalta dotterbolag och äga fast, lös och intellektuell egendom inom Bioprinting.
Address
Långfilsgatan 7
Phone
+4631128700
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 74 236 | 144 816 | 116 964 | 89 824 |
| Staff expenses | — | — | — | — |
| EBITDA | −26 950 | −70 444 | −24 923 | −104 253 |
| Depreciation & amort. | −5 | −29 944 | −34 096 | −131 170 |
| EBIT | −26 955 | −100 388 | −59 019 | −235 423 |
| Net financials | −409 | −8 891 | −10 632 | −10 730 |
| Profit before tax | −27 364 | 27 590 | −64 850 | 42 824 |
| Tax | −0 | −3 029 | −0 | 36 |
| Net profit | −27 364 | 24 561 | −64 850 | 42 860 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 395 773 | 408 019 | 375 847 | 321 332 |
| Equity | 13 281 | 81 597 | 14 630 | 57 561 |
| Long-term debt | 306 150 | 117 600 | 117 600 | 117 600 |
| Short-term debt | 75 559 | 157 146 | 196 801 | 94 231 |
| Total debt | 381 709 | 274 746 | 314 401 | 211 831 |
EBITDA margin
-116.1%
This company
15.8%
Market median
-835% vs market
20212024
Equity ratio
17.9%
This company
38.2%
Market median
-53% vs market
20212024
Return on equity
74.5%
This company
18.4%
Market median
+305% vs market
20212024
Net profit margin
47.7%
This company
8.1%
Market median
+489% vs market
20212024
Asset turnover
0.28×
This company
1.12×
Market median
-75% vs market
20212024
Debt / equity
4.58×
This company
0.62×
Market median
-639% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ÅH Chief Auditor | Chief Auditor | 2024 |
AP Chief Executive Officer | Chief Executive Officer | 2026 |
| Former (3) | ||
FP Chief Auditor | Chief Auditor | 2022 – 2024 |
CM Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
AS Chief Executive Officer | Chief Executive Officer | 2024 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2026 | |
| Former (5) | ||
| Board of Directors | 2022 – 2026 | |
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2022 – 2022 | |
| Chairman | 2022 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BICO Group AB
CELLINK Bioprinting AB Board members of CELLINK Bioprinting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fredrik Pierre Roger Jonsson | Chief Auditor | 0 companies |
| Cecilia Margareta Edebo | Chief Executive Officer | 0 companies |
| Anders Stefan Blomsterberg | Chief Executive Officer | 0 companies |
| Åsa Helena Löfqvist | Chief Auditor | 0 companies |
| Anders Peter Fogelberg | Chief Executive Officer | 0 companies |
| Bo Lars Risberg | Board of Directors | 0 companies |
| Hans Jacob Eric Thordenberg | Board of Directors | 0 companies |
| Albert Andréas Joersjö | Board of Directors | 0 companies |
| Ewa Maria Olsson Linsäter | Board of Directors | 0 companies |
| Eva Charlotte Bus | Board of Directors | 0 companies |
| Gusten Danielsson | Board of Directors | 0 companies |
| Marius Adam Balger | Chairman | 0 companies |